To conduct this first pharmacological experiment, effective, high doses of the compounds, validated in preclinical models with metabolic alterations 33,34,35,41,42 , were selected
2 Search strategy and inclusion criteria This mini-review was based on a targeted literature search conducted in PubMed/MEDLINE and Scopus from January 2015 to August 2025, using the keywords GLP-1 receptor agonists, exercise, physical activity, obesity, type 2 diabetes, and weight loss. Additional terms ( lean mass, body composition, insulin sensitivity, cardiometabolic, combined intervention ) were used in secondary searches
This combination demonstrates significant tumor suppression, positioning morin hydrate as a promising adjuvant for resistant cancers (169)
670 STAT3 protects ND1 and SDH activity from ischemic damage, acting as a ROS scavenger by reducing ROS production from respiratory chain complexes I and II